•  1-800-399-VETS
  •  

    Due to the Thanksgiving holiday, our offices and distribution center will be closed on Thursday, November 23rd and Friday, November 24th

    The last day to ship temperature controlled items for next day delivery will be on Tuesday, November 21st. Temperature-controlled items ordered after November 21st will be delivered on Tuesday, November 28th.

    Normal orders placed on Wednesday, November 22nd will be delivered on Friday, November 24th or Monday, November 27th

    Customers are encouraged to place their orders as soon as possible to avoid shipping delays. Feel free to reach out to your sales representative for any special needs. 

    Thank you for your continued support throughout the years. Have a Happy Thanksgiving!

     


    Meet the Team

    dicrisci

    Robert DiCrisci
    Founder, Chairman & CEO

    Robert DiCrisci is the Founder, Chairman, CEO of Tri-Source Pharma, the parent company of NextSource Biotechnology, Ivaoes Animal Health and Amatheon Pharmaceuticals.

    Mr. DiCrisci has over 20 years of leadership experience in the Healthcare, Pharmaceutical and Technology markets. He began his career as a Lead Project Manager of Business Development for the Microsoft Business Solutions client base operating within the Healthcare/Pharmaceutical space. As a Business Management and Computer Science educated/Certified Systems Engineer, he held strategic business development/technology management roles in companies such as Cosabella Inc., Health Coalition Inc., University of Michigan Health, AAA Auto Club Group, HRH Construction and Sirco Associates.

    Upon moving from his previous business consulting role, he became an Executive Director for Medical Staffing Network (MSN), the largest publicly traded medical staffing firm in the nation. During his tenure, Mr. DiCrisci took part in a capital raise of $185M in equity and $120M in a debt facility. Shortly thereafter he worked with the financial team to prepare the company for its Initial Public Offering (IPO). Additionally, Mr. DiCrisci’s responsibilities included managing and integrated over 30+ M&A deals, opening over three hundred DeNovo locations nationwide and managing all corporate operations, IT, business development and finance departments which were comprised of over seven hundred employees and over 20,000 per diem nurses. As a rapid growth company, we achieved revenues exceeding $500M in annual sales. After leaving Medical Staffing Network, Mr. DiCrisci Co-founded Amatheon Pharmaceuticals and has spent over 14 years building it into the leading distributor of human approved specialty pharmaceuticals for use in the animal health sector nationwide. Mr. DiCrisci served as the President, CEO of Amatheon and was responsible for managing and overseeing all aspects of the business with special attention on finance, Information technology, sales, marketing and business development. While running Amatheon, Mr. DiCrisci then founded NextSource Biotechnology, an FDA approved manufacturer of brand and generic human drugs and Ivaoes Animal Health, an FDA approved manufacturer of veterinary approved Brand and Generic drugs. These two companies work together to Identify, consolidate and develop a pipeline of new animal approved drugs (Cross-Over Medications). These drugs are predominately sold into the animal health industry and represent a market value of $3B annually.

    View LinkedIN Profile: www.linkedin.com/in/RobDicrisci

    mohamad

    Mohamad Osman
    President, COO

    Prior joining Amatheon Pharmaceuticals, Mr. Osman founded Osman Page in 2005, Mr. Osman spent the majority of his career as the Director of Financial Operations for a $500 MM publicly traded healthcare company, Medical Staffing Network, located in Boca Raton, FL. During his tenure with MSN, Mohamed was instrumental in completing the acquisition of over 30 companies, opening more than 300 locations across the country, and growing the company to 700 plus employees and 20,000 Temporary Nurses within a five-year period. This period of growth resulted in a private equity raise of $185 MM from the global investment firm of Warburg Pincus along with the acquisition of a $120 MM debt facility in 2001. In 2002, the work of the senior management team culminated in an Initial Public Offering (IPO) of $170.6 MM.

    Mr. Osman brings more than 20 years of business experience in Accounting & IT to Amatheon Pharmaceuticals. He holds a B.S. degree in Accounting along with an MBA in Technology Management. In addition, Mr. Osman is a CISA (Certified Information Systems Auditor).

    Copyright © 2015 Amatheon Inc. All Rights Reserved. Privacy Policy |  Terms of Use | Store Policy
    livechat